The answer to regenerative medicine's most compelling question —why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot — may lie with the body's innate immune system, according to a new study of heart regeneration in the axolotl, or M
You are here
Coverage of the latest news and updates from the field of stem cells.
In the future people with diabetes might benefit from getting insulin-regulating beta cells transplanted into their body because their own beta cells are destroyed or less functional.
Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. It is already in use in a breast cancer clinical trial.
Researchers have detailed an underlying mechanism that leads to a major health problem for older people, osteoporosis. When this mechanism malfunctions, progenitor cells stop creating bone-producing cells and instead create fat cells.
Scientists from the cluster of excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg and the Freiburg University Medical Center have shown that inhibiting the epigenetic regulator KDM4 might offer a potential novel treatment option for breast cancer patients.
Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called “epigenetic” changes in the cells consistent with the earliest steps toward lung cancer development.
India’s Department of Biotechnology announced that it has implemented a cooperative program with Japan to accelerate the application of stem cell technology in human disease with four institutions from India participating with the Centre for iPS Cell Research and Application (CiRA), Kyoto Univers
Scientists at the Scripps Research Institute (SRI) have found a new approach to the “reprogramming” of ordinary adult cells into stem cells.
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Cellect Biotechnology Ltd.'s ApoGraft™ for the prevention of acute and chronic graft versus host disease(GvHD) in transplant patients. Cellect is a developer of stem cells selection technology.
Macular degeneration is the leading cause of vision loss in older adults, but scientists have long struggled to study and replicate key elements of the disease in the lab.